China Pharma Holdings, Inc. (CPHI) SEC Filings — 2024
14 SEC filings for China Pharma Holdings, Inc. (CPHI) in 2024.
Filings
- China Pharma Holdings Reports on Shareholder Votes — 8-K · Dec 26, 2024
- China Pharma Holdings Enters Material Definitive Agreement — 8-K · Dec 13, 2024
- China Pharma Holdings Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- China Pharma Holdings Files 2024 Proxy Statement — DEF 14A · Nov 12, 2024
- China Pharma Holdings Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- China Pharma Holdings Files 8-K with Material Agreement — 8-K · May 30, 2024
- China Pharma Holdings, Inc. Files 10-Q for Q1 2024 — 10-Q · May 15, 2024
- China Pharma Holdings Changes Auditors — 8-K · May 8, 2024
- China Pharma Holdings, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- China Pharma Partners on Liver Disease Drug — 8-K · Mar 29, 2024
- CHINA PHARMA HOLDINGS Files 8-K on Feb 23 — 8-K · Feb 23, 2024
- CPHI Sells Unregistered Equity Securities, Raising Capital — 8-K · Feb 8, 2024
- Tao Liu Acquires 19.9% Stake in China Pharma Holdings (CPHI) — SC 13G · Jan 26, 2024
- Streeterville Capital Amends China Pharma Holdings Stake — SC 13G/A · Jan 12, 2024